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CAH – reminder of key points
• An adrenal enzyme defect
• Classical 21-hydroxylase deficiency is the most 
common
– 1 in 15,000 births in the UK
• Results in glucocorticoid and mineralocorticoid 
deficiency
– ↑ ACTH secretion by the anterior pituitary
– Accumulation of steroid precursors prior to the enzyme 
defect
– ↑ androgens production
Diagnosis in Boys
• Can have hyperpigmented scrotum and 
genitalia at birth, but usually look ‘normal’
• Presentation
– Day 5
– Second week of life
• Poor feeding, weight loss, failure to thrive
– If CAH not recognised
• Salt losing crisis
– Due to the aldosterone loss
Diagnosis in Girls
• Genitalia are usually virilized due to excess 
testosterone
– Allows earlier diagnosis
• Mild clitoromegaly to full masculinisation
– Prader staging
• DSD service
Diagnosis
• Confirmed by a raised 17OHP level after day 3 
of life
• Salt wasting confirmed by:
– Low plasma sodium
– High potassium
– Increased urinary sodium excretion
– Virilised girls
• Chromosome analysis
• Pelvic ultrasound
Biochemical investigations
• Short synacthen test
• Synacthen given IM or IV
– 0 – 6 months: 62.5mg 
• Urine
– Steroid analysis to confirm the 21-hydroxylase 
deficiency defect
Time Cortisol 17-OHP 11-DOC A4 ACTH Renin
0 √ √ √ √ √ √
30 √ √ √ √
60 √ √ √ √
Medical management 
• Hydrocortisone 10mg tablets
– 10 – 15 mg/m2/day
– Total dose spread 3 – 4 times throughout the day
• Fludrocortisone 100 mcg tablets
– 150 mcg / m2/ day
• Salt supplements
– Oral salt supplements (until one year of age) in the 
5mmol/ml 30% Sodium Chloride solution –
5mmols/kg/day, in 4 divided doses = …….mls per dose 
four times a day
– Can stop when fully weaned
Classification of DSD
• 46,XY DSD (under virilised 
genetic male)
– Disorders of testicular 
development
• Ovotesticular DSD
– Disorders of androgen 
synthesis / action
• CAIS
– Others
• Hypospadias
• 46,XX DSD (over virilised 
genetic female)
– Disorders of ovarian 
development
• Ovotesticular DSD
– Androgen excess
• CAH
• Sex chromosome DSD 
(variable)
– Turner’s syndrome
– Klinefelter’s syndrome
– Mixed gonadal dysgenesis
Lee et al (2006)
Consensus Statement on 
Management of Intersex Disorders
46XX CAH in DSD service
• Ambiguous genitalia
– More than half of all infants born with AG are 46XX
• Due to in utero exposure of androgens 
• Source may be adrenal (CAH) or testicular
• Complex congenital malformations
– Cloacal extrophy, or bladder extrophy
• Gradual clitoris enlargements during childhood
– Non classical CAH
• Abnormal developments at puberty
– Primary amenorrhoea
• No breast or pubic hair development (46XX gonadal dysgenesis or 
steroid biosynthetic defects) OR
• Normal breast and pubic hair development (Mullerian duct agenesis)
• Normal breast development but little or no pubic hair (CAIS)
GOSH DSD data over 21 years N= 657
46XX CAH
• Baby will have been exposed to 
excess male hormone in-utero
• The genitalia will look like a boy’s:
– Labia will fuse to look like a 
scrotum
– Clitoris enlarges and looks like 
a penis
• Can sometimes be so severe, sex 
assignment is difficult
– Need karyotype
– Will still have normal internal 
structures
– Surgery may be needed to 
correct outer appearance
• CONTROVERSIAL
• Exposure to prenatal androgens and 
Prader III virilisation at birth
• Same baby at age 8 weeks at the 
time of genital reconstruction, 
showing some regression of 
virilisation after
starting steroid 
treatment
• Another baby girl with a more 
severe form of 21OHD,
leading to more
severe 
virilisation 
(Prader IV)
46XX Gonadal Dysgenesis
• Mutations in FSH receptor gene has been identified
• ‘Pure’ without features of Turner Syndrome
• Streak gonads are present due to germ cells not forming properly
– Mostly composed of fibrous tissue
• Characterised by primary amenorrhoea with or without 
secondary sexual characteristics
46XX Mullerian Duct Agenesis
• Vaginal agenesis usually associated with an absent uterus  
and fallopian tubes but with normal ovarian development
– Mayer–Rokitansky–Küster–Hauser syndrome
Case study
• 3/52 baby girl
– 2nd opinion
– ? Future management
• Born at term
• Weight 4.53kg
• Non-consanguineous parents
• No family history of any DSD
Case study
• Ante-natal USS
– Boy
• Baby born
– Male sex of rearing 
assigned
– Given a male name
• Post natal check
– No testes in scrotum
• Urgent USS..
• Normal bladder and 
kidneys
• No testes or ovaries
• Chromosomes
– 46XX
• Bloods
– ↑ 17OHP
– 101.9 nmol/L (normal 
range 0– 5 nmol/L)
• Local Paediatrician
– 21OHD CAH
– Hydrocortisone and 
Fludrocortisone
Referral 
• Parents very anxious
– Genital reconstructive surgery
– Father very angry
• Referral into the DSD MDT
• On examination
– Prader V in Prader scoring system
Further investigations
• Repeat Pelvic USS
– No testes
– Ovaries seen
• Review of management, including intensive 
support and input from CNS
Change from hydrocortisone suspension to tablets
Medication review
• Stay on same dose of Fludrocortisone
• Hydrocortisone suspension three times a day
– 2/2/3mg
• Changed to hydrocortisone 10mg tablets 
• 1.25mg four times a day
• Guidance given on crushing and mixing with water  breast milk
• Dosage titrated against BSA calculations
– Side effects of underdosing → androgenisation
– Side effects of overdosing → Cushings
– Regular bloods
• Intensive emergency management training
– x 3 emergency hydcrocortisone packs prescribed and 
administered
CNS relationship with family
• Advanced knowledge on prescribing 
– Builds strong, trusting relationship with family
– ? Increased compliance
– Key team liaison
• Any concerns
• Difficulties with prescription
– Liaison with Primary Care
• GP
• Health Visitors
– School
– ? Reduce unnecessary trips to GP /
Hospital for specialised repeat 
prescriptions
Why tablets?
• Hydrocortisone 
suspension not 
bioequivalent to 
Hydrocortisone tablets 
(Merke, 2001)
• Instructions given:
– Cutting and crushing 
tablets
Suspension v tablets
• ↑ need for higher 
hydrocortisone doses in 
children on liquid 
hydrocortisone
– Inadequate control of 
androgens
– Signs and symptoms of 
Cushing’s syndrome
– Endocrine Society Clinical 
Practice Guideline (2010)

GP letter on discharge
• Medication onto 
repeat 
prescription 
system
• Tablets not 
suspension
• Also highlights 
that the baby can 
have all of their 
usual childhood 
immunisations
Clinical nurse specialist roles
Clinical 
nurse 
specialist
Consultant
Educator
Researcher
Collaborator
Leader
Change 
Agent
Patient
advocate
Liaison
CNS advocate role – at diagnosis
• Ensure referring team has parents 
admission leaflet
• Liaising with the MDT
– From the referring team and also 
the team being referred to
– Is the baby well / hospitalised
– Are they requiring transport / nurse 
escort / will that nurse stay with 
patient
• Liaising with the ward
– Ensure GnRH, Synacthen and HCG in 
stock on ward if need be
• Liaising with the parents!
• Prepare information packs for 
parents
– DSD families leaflet
– Cortisol deficiency booklets
– CAH information
– CNS contact details
• How is the baby feeding
– Breast pump, bottles, quiet area 
available
– Bottle feeding – enough milk
• Ensure parents bring
– Phone chargers, nappies, wipes, books 
etc, lists of questions
– Maternity notes, child health care notes, 
referral letters
– Money for parking
• Can they speak English
– Arrange interpreter, prepare translated 
information 
CNS advocate role - ongoing
• Key liaison and support for family
• Involvement in support groups / 
support group days
• Be knowledgeable in specific 
condition and long term
implications
– Prepared for discussions on puberty 
and 
adolescence and beyond
• Liaise with adult DSD / gynaecology
teams
• Patient and family empowerment
Conclusion
• Complexity of 46XX CAH discussed
• DSD service
• Management
– Medical
– Nursing
• Focus on nursing roles
• Optimise patient care
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